Newborn Genetic Screening

Newborn genetic screening is the practice of testing every newborn for certain harmful or treatable genetic disorders in newborn infants.  Babies with these conditions appear normal at birth. It is only with time that the conditions affects the baby’s brain or physical development or causes other medical problems. By then the damage may be permanent.  Early diagnosis and treatment can result in normal growth and development and can reduce morbidity and mortality.

  • Neonatal Cellular Bioenergetics
  • Neonatal Screenings
  • Phenylketonuria (PKU)
  • Neonatal Pharmacokinetics
  • Neonatal Seizures
  • Genetic Abnormalities

Related Conference of Newborn Genetic Screening

April 16-17, 2026

5th International Congress on Pediatrics

Tokyo, Japan
April 20-21, 2026

10th World Pediatrics Conference

Paris, France
April 20-21, 2026

3rd World Congress on Pediatrics and Nutrition

Paris, France
April 23-24, 2026

11th Annual Pediatric Congress

Paris, France
May 21-22, 2026

11th Annual Summit on Pediatric Cardiology

Boston, USA
May 21-22, 2026

39th World Pediatrics Conference

Paris, France
May 27-28, 2026

38th European Pediatrics Congress

Paris, France
June 04-05, 2026

30th World Nutrition and Pediatrics Healthcare Conference

Zurich, Switzerland
June 11-12, 2026

27th Annual World Congress on Pediatrics

Barcelona, Spain
June 22-23, 2026

35th World Congress on Clinical Pediatrics

Barcelona, Spain
July 27-28, 2026

3rd World Pediatric Conference

London, UK
September 14-15, 2026

26th Annual Congress on Pediatrics & Neonatology

Rome, Italy
November 19-20, 2026

37th European Pediatrics Conference

Dubai, UAE

Newborn Genetic Screening Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in